Clinical trials
Phase 1/2 Thalassemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Hospital of Philadelphia | 2 |
| Gamida Cell ltd | 2 |
| Children's Hospital Los Angeles | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Talaris Therapeutics Inc. | 1 |
| University of Florida | 1 |
| Weill Medical College of Cornell University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thalassemia | 9 |
| Anemia, Sickle Cell | 6 |
| Anemia, Diamond-Blackfan | 2 |
| Bone Marrow Failure Disorders | 2 |
| Genetic Diseases, Inborn | 2 |
| Granulomatous Disease, Chronic | 2 |
| Lymphoproliferative Disorders | 2 |
| Mucopolysaccharidosis I | 2 |
| Wiskott-Aldrich Syndrome | 2 |
| beta-Thalassemia | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.